ljc 10627 has been researched along with Disease Models, Animal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhaskar, A; Chaturvedi, S; Dwivedi, VP; Ghoshal, A; Kumari, A; Mukhopadhyay, S; Pahuja, I; Shaji, A; Verma, A | 1 |
| Bae, JS; Baek, MC; Choo, S; Kim, J; Sim, H | 1 |
| Ammerman, NC; Dooley, KE; Dorman, SE; Kaushik, A; Lamichhane, G; Nuermberger, EL; Story-Roller, E; Tasneen, R | 1 |
| Araki, N; Harada, Y; Hasegawa, H; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Morinaga, Y; Yamada, K; Yamamoto, Y; Yanagihara, K | 1 |
| Hikida, M; Kawabata, T; Maebashi, K; Niida, M; Sakakibara, S; Takata, T | 1 |
| Hikida, M; Ito, F; Kataoka, H; Kijima, K; Maebashi, K; Mikami, Y; Muto, Y; Niida, M; Sakakibara, S; Shimizu, A; Suzuki, K; Takata, T; Takeda, K; Unno, M | 1 |
| Lahnborg, G; Nord, CE | 2 |
8 other study(ies) available for ljc 10627 and Disease Models, Animal
| Article | Year |
|---|---|
Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; CD8-Positive T-Lymphocytes; COVID-19; Disease Models, Animal; Immunity; Immunologic Factors; Mice; Mycobacterium tuberculosis; Tuberculosis | 2023 |
Biapenem reduces sepsis mortality via barrier protective pathways against HMGB1-mediated septic responses.
Topics: Animals; Cell Movement; Cells, Cultured; Disease Models, Animal; HMGB1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Sepsis; Signal Transduction; Thienamycins | 2021 |
In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Female; Mice, Inbred BALB C; Microbial Viability; Mycobacterium tuberculosis; Rifampin; Thienamycins; Treatment Outcome; Tuberculosis | 2017 |
In vivo efficacy and pharmacokinetics of biapenem in a murine model of ventilator-associated pneumonia with Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Colony Count, Microbial; Disease Models, Animal; Histocytochemistry; Lung; Male; Meropenem; Mice; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms; Statistics, Nonparametric; Thienamycins | 2012 |
[Combined effects of arbekacin with biapenem against in vitro and in vivo model of a mixture of MRSA and Pseudomonas aeruginosa].
Topics: Aminoglycosides; Animals; Anti-Infective Agents; Dibekacin; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Thienamycins | 2004 |
Pharmacokinetic and pharmacodynamic properties of biapenem, a carbapenem antibiotic, in rat experimental model of severe acute pancreatitis.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Ascites; Bacterial Infections; Disease Models, Animal; Dose-Response Relationship, Drug; Imipenem; Injections, Subcutaneous; Intestines; Lymph Nodes; Male; Pancreas; Pancreatitis; Rats; Rats, Wistar; Severity of Illness Index; Taurocholic Acid; Thienamycins | 2008 |
Biapenem versus imipenem in the treatment of experimental intraabdominal infections.
Topics: Abdomen; Animals; Bacteria; Bacterial Infections; Disease Models, Animal; Imipenem; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Thienamycins | 1995 |
Efficacy of L-627, a new carbapenem, in the treatment of experimentally induced intra-abdominal infections in rats.
Topics: Abdomen; Animals; Bacterial Infections; Carbapenems; Disease Models, Animal; Gentamicins; Intestines; Male; Metronidazole; Rats; Rats, Sprague-Dawley; Thienamycins | 1992 |